Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer
Study Information
Alliance Study ID: A221504
NCT Study ID (ClinicalTrials.gov): NCT03087708
Alliance Committee: Cancer Control
Disease or Cancer Type: Lung Cancer & Mesothelioma
Alliance Study Chair: Pankaj Gupta, MD
Status: TERMINATED
Study Description
This randomized pilot clinical trial studies the side effects and best dose of naloxegol and to see how well it works in treating patients with stage IIIB-IV non-small cell lung cancer. Naloxegol may relieve some of the side effects of opioid pain medication and fight off future growth in the cancer.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information